[Statement on tuberculosis treatment]

Ugeskr Laeger. 1973 Aug 20;135(34):1829-30.
[Article in Danish]
No abstract available

MeSH terms

  • Aminosalicylic Acids / adverse effects
  • Aminosalicylic Acids / therapeutic use
  • Antitubercular Agents / therapeutic use*
  • Drug Resistance, Microbial
  • Drug Therapy, Combination
  • Dyspepsia / chemically induced
  • Ethambutol / therapeutic use
  • Ethionamide / therapeutic use
  • Humans
  • Isoniazid / therapeutic use
  • Pyrazinamide / therapeutic use
  • Rifampin / therapeutic use
  • Streptomycin / adverse effects
  • Streptomycin / therapeutic use
  • Thiosemicarbazones / therapeutic use

Substances

  • Aminosalicylic Acids
  • Antitubercular Agents
  • Thiosemicarbazones
  • Pyrazinamide
  • Ethambutol
  • Ethionamide
  • Isoniazid
  • Rifampin
  • Streptomycin